Telmefixx Adverse Reactions

Least as frequent in the placebo group; influenza-like symptoms, dyspepsia, myalgia, urinary tract infection, abdominal pain, headache, dizziness, pain, fatigue, coughing, hypertension, chest pain, nausea and peripheral edema. The incidence of adverse events was not dose-related and did not correlate with gender, age, or race of patients. The incidence of cough occurring with Telmisartan in six placebo-controlled trials was identical to that noted for placebo-treated patients (1.6%). In addition, it cannot be determined whether these events were causally related to Telmisartan tablets: Autonomic Nervous System: Impotence, increased sweating, flushing.
Body as a Whole: Allergy, fever, leg pain, malaise.
Cardiovascular: Palpitation, dependent edema, abnormal ECG.
CNS: Insomnia, somnolence, migraine, vertigo, paresthesia, involuntary muscle contractions, hypoesthesia.
Gastrointestinal: Flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, non-specific gastrointestinal disorders.
Metabolic: Gout, hypercholesterolemia, diabetes mellitus.
Musculoskeletal: Arthritis, arthralgia, leg cramps.
Psychiatric: Anxiety, depression, nervousness.
Resistance Mechanism: Infection, fungal infection, abscess, otitis media.
Respiratory: Asthma, bronchitis, rhinitis, dyspnea, epistaxis.
Skin: Dermatitis, rash, eczema, pruritus.
Urinary: Micturition frequency, cystitis.
Vascular: Cerebrovascular disorder.
Special Senses: Abnormal vision, conjunctivitis, tinnitus, earache.
During initial clinical studies, a single case of angioedema was reported (among a total of 3,781 patients treated).